Purpose Male breast cancer (BC) is rare, representing approximately 1% of cancers that
occur in men and approximately 1% of all BCs worldwide. Because male BC is rare, not …

Breast Cancer in Men Breast cancer in men accounts for about 1% of all breast cancers and
is mainly estrogen-receptor–positive. Few prospective studies of treatment in men have …

PURPOSE To develop recommendations concerning the management of male breast
cancer. METHODS ASCO convened an Expert Panel to develop recommendations based …

Occurrence of male breast cancer, a rare disease, peaks at age 71 years. Familial cases
usually have BRCA2 rather than BRCA1 mutations. Occupational risks include high …

The 1st international Consensus Conference for Advanced Breast Cancer (ABC 1) took
place on November 2011, in Lisbon. Consensus guidelines for the management of this …

Unlike female breast cancer, male breast cancer (MBC) is rare and not very well understood.
Prospective data in the management of MBC are lacking and majority of treatment strategies …

Male breast cancer (MaBC) is a rare clinical entity, which makes up approximately 1% of all
breast cancers. However, the incidence of MaBC has been steadily increasing over the past …

Male breast carcinoma is a rare condition. Few male breast cancer-specific epidemiological
or clinical trial data are available-our understanding of male breast cancer thus comes from …

Male breast cancer is rare, accounting for 1% of all breast cancer diagnoses in the USA.
Because of its rarity, most major breast cancer trials have included only female patients. This …

Breast cancer is the most prevalent type of cancer in women and responsible for significant
female cancer-related mortality worldwide. In the Western world, over 80% of breast cancers …